Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (898)
    • Blood Glucose Meters (9)
    • Complications (201)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (83)
    • Drug-Induced Hypo/Hyperglycemia (140)
    • Monitoring (139)
    • Natural Medicines/Supplements (9)
    • Prevention (47)
    • Treatment (371)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (85)
      • Glitazones (129)
      • GLP-1 (41)
      • Incretin Enhancers/Mimetics (82)
      • Insulin (197)
      • Meglitinides (46)
      • Metformin (165)
      • SGLT2 Inhibitors (86)
      • Sulfonylureas (131)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (9)
  • Hyperglycemia (39)
  • Hypoglycemia (19)
  • Other (31)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (63)
121 - 135 of 371 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Choosing Metformin Add-Ons February 2017
Article: Adlyxin and Soliqua Join a Crowded Market of Injectable Diabetes Meds January 2017
Article: Jardiance (empagliflozin) improving CV outcomes January 2017
Article: Avoid Mix-Ups With Tradjenta, Trulicity, Tanzeum, Toujeo, and Tresiba December 2016
Article: Don't Recommend Non-Insulin Diabetes Meds for Most Type 1 Patients December 2016
Article: Use the Appropriate Dose of Basaglar When Switching From Other Insulins December 2016
Commentary: GLP-1 Agonists in Type 1 Diabetes December 2016
Article: Dispense the New U-500 Syringes to Avoid Dangerous Dosing Errors November 2016
Article: Don't Jump to Insulin Even if Glucose is Very High in New-Onset Type 2 Diabetes October 2016
Article: Watch for Gallbladder Problems in Patients Using GLP-1 Agonists October 2016
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
PL Voices: Treatment of Newly-Diagnosed Type 2 Diabetes October 2016
Commentary: GLP-1 Agonists and Gallbladder Disease October 2016
Article: Remind Heart Failure Patients to Watch for Sodium in OTCs September 2016
PL Voices: Meds to Avoid in Heart Failure Patients September 2016
  • « Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved